Location History:
- Dobbs Ferry, NY (US) (2000 - 2003)
- New York, NY (US) (2006 - 2010)
Company Filing History:
Years Active: 2000-2010
Title: The Innovative Contributions of Anne M Gurnett
Introduction
Anne M Gurnett is a notable inventor based in Dobbs Ferry, NY (US). She has made significant contributions to the field of biotechnology, particularly in the development of antiprotozoal agents. With a total of 5 patents to her name, Gurnett's work has had a meaningful impact on the scientific community.
Latest Patents
One of her latest patents is titled "Toxoplasma gondii cyclic GMP dependent protein kinase G as a chemotherapeutic target for antiprotozoal agents." This invention focuses on protozoal cyclic GMP dependent protein kinases that have been isolated and cloned. These enzymes are crucial for screening assays aimed at identifying potential antiprotozoal agents. Additionally, the patent discusses novel protozoal cyclic GMP dependent protein kinases and the nucleic acid molecules that encode them. The invention also includes methods for obtaining these nucleic acid molecules, proteins, antibodies, and inhibitors, as well as therapeutic compositions that can protect animals from diseases caused by parasites.
Career Highlights
Throughout her career, Gurnett has worked with prominent companies such as Merck & Company, Inc. and Merial Limited. Her experience in these organizations has allowed her to contribute to groundbreaking research and development in her field.
Collaborations
Gurnett has collaborated with esteemed colleagues, including Dennis M Schmatz and Sandra J Rattray. These partnerships have further enhanced her research and innovation efforts.
Conclusion
Anne M Gurnett's contributions to biotechnology and her innovative patents demonstrate her commitment to advancing science and improving health outcomes. Her work continues to inspire future generations of inventors and researchers.